CVS HEALTH CORPORATION Debt Securities, Available-for-sale, Amortized Cost
CVS HEALTH CORPORATION (CVS) had Debt Securities, Available-for-sale, Amortized Cost of $22.28 billion as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2024-02-07
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $22.28B.
- 2023-09-30: Debt Securities, Available-for-sale, Amortized Cost $22.10B.
- 2023-06-30: Debt Securities, Available-for-sale, Amortized Cost $22.27B.
- 2023-03-31: Debt Securities, Available-for-sale, Amortized Cost $22.12B.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2023-12-31 | $22.28B 10-K · filed 2024-02-07 |
| 2023-09-30 | $22.10B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $22.27B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $22.12B 10-Q · filed 2023-05-03 |
| 2022-12-31 | $22.07B 10-K · filed 2024-02-07 |
| 2022-09-30 | $22.25B 10-Q · filed 2022-11-02 |
| 2022-06-30 | $22.21B 10-Q · filed 2022-08-03 |
| 2022-03-31 | $22.84B 10-Q · filed 2022-05-04 |
| 2021-12-31 | $22.17B 8-K · filed 2023-05-25 |
| 2020-09-30 | $18.86B 10-Q · filed 2020-11-06 |
| 2020-06-30 | $17.11B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $16.14B 10-Q · filed 2020-05-06 |
| 2019-12-31 | $15.90B 10-Q · filed 2020-11-06 |
| 2019-09-30 | $15.71B 10-Q · filed 2019-11-06 |
| 2019-06-30 | $15.59B 10-Q · filed 2019-08-07 |
| 2019-03-31 | $15.34B 10-Q · filed 2019-05-01 |
| 2018-12-31 | $15.12B 10-K · filed 2020-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |